Case Report
Volume: 8 | Issue: 3 | Published: Apr 02, 2024 | Pages: 53 - 56 | DOI: 10.24911/ejmcr.173-1701008366
Treatment of Osgood-Schlatter Disease in an Adolescent Athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel: A Case Report
Authors: Torbjorn Ogeus
Article Info
Authors
Torbjorn Ogeus
Karlavägen 1, Stockholms led- & smärtklinik
Publication History
Received: November 26, 2023
Revised: February 03, 2024
Accepted: February 10, 2024
Published: April 02, 2024
Abstract
Introduction: Knee pain is one of the most frequent musculoskeletal symptoms in young physically active males. In some cases, it is very painful, can be hard to treat, and often lead to heterotopic ossification of the patellar tendon. To our knowledge, there are no reported cases of remission of ossification after clinical intervention. Case presentation: A 13-year-old Swedish boy with a 3-year anamnesis of severe Osgood-Schlatter with significant ossification of the patellar tendon at the point of tuberositas tibiae, was treated with injections of Liquid Platelet-Rich Fibrin (C-PRF) and Heat-Coagulated Albumin Gel (ALB-PRF) using a horizontal centrifuge system. He recovered and presented a near complete remission of ossification of the patellar tendon two months after treatment and could return to sport after a 3-year break. Conclusion: This case raises the hypothesis that Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel may be an effective intervention in the treatment of Osgood-Schlatter disease. Further research is required to test this theory.
Keywords: Osgood-Schlatter, PRF, ALB-PRF, PRP, green
Pubmed Style
Torbjorn Ogeus. Treatment of Osgood-Schlatter Disease in an Adolescent Athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel: A Case Report. EJMCR. 2024; 02 (April 2024): 53-56. doi:10.24911/ejmcr.173-1701008366
Web Style
Torbjorn Ogeus. Treatment of Osgood-Schlatter Disease in an Adolescent Athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel: A Case Report. https://ejmcr.com/articles/1254 [Access: December 25, 2024]. doi:10.24911/ejmcr.173-1701008366
AMA (American Medical Association) Style
Torbjorn Ogeus. Treatment of Osgood-Schlatter Disease in an Adolescent Athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel: A Case Report. EJMCR. 2024; 02 (April 2024): 53-56. doi:10.24911/ejmcr.173-1701008366
Vancouver/ICMJE Style
Torbjorn Ogeus. Treatment of Osgood-Schlatter Disease in an Adolescent Athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel: A Case Report. EJMCR. (2024), [cited December 25, 2024]; 02 (April 2024): 53-56. doi:10.24911/ejmcr.173-1701008366
Harvard Style
Torbjorn Ogeus (2024) Treatment of Osgood-Schlatter Disease in an Adolescent Athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel: A Case Report. EJMCR, 02 (April 2024): 53-56. doi:10.24911/ejmcr.173-1701008366
Chicago Style
Torbjorn Ogeus. "Treatment of Osgood-Schlatter Disease in an Adolescent Athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel: A Case Report." 02 (2024), 53-56. doi:10.24911/ejmcr.173-1701008366
MLA (The Modern Language Association) Style
Torbjorn Ogeus. "Treatment of Osgood-Schlatter Disease in an Adolescent Athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel: A Case Report." 02.April 2024 (2024), 53-56. Print. doi:10.24911/ejmcr.173-1701008366
APA (American Psychological Association) Style
Torbjorn Ogeus (2024) Treatment of Osgood-Schlatter Disease in an Adolescent Athlete with Liquid Platelet-Rich Fibrin and Heat-Coagulated Albumin Gel: A Case Report. , 02 (April 2024), 53-56. doi:10.24911/ejmcr.173-1701008366